Related Experiment Video
Updated: Jul 11, 2025

Lung Tumor Cell Recruitment Assay
Published on: February 26, 2019
ANKRD49 promotes the metastasis of NSCLC via activating JNK-ATF2/c-Jun-MMP-2/9 axis
Jia Sun1,2, Jin-Rui Hu3, Chao-Feng Liu1
1Department of Pulmonary and Critical Care Medicine, Shanxi Province Key Laboratory of Respiratory Disease, the First Hospital, Shanxi Medical University, NHC Key Laboratory of Pneumoconiosis, Taiyuan, Shanxi, 030001, China.
Background:
Ankyrin repeat domain 49 (ANKRD49) has been found to be highly expressed in multiple cancer including lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC). However, the function of ANKRD49 in the pathogenesis of NSCLC still remains elusive. Previously, ANKRD49 has been demonstrated to promote the invasion and metastasis of A549 cells, a LUAD cell line, via activating the p38-ATF-2-MMP2/MMP9 pathways. Considering the heterogeneity of tumor cells, the function and mechanism of ANKRD49 in NSCLC need more NSCLC-originated cells to clarify.
Methods:
Real-time qPCR was employed to test ANKRD49 expression levels in nine pairs of fresh NSCLC tissues and the corresponding adjacent normal tissues. The function of ANKRD49 was investigated using overexpression and RNA interference assays in lung adenocarcinoma cell line (NCI-H1299) and lung squamous carcinoma cell line (NCI-H1703) through gelatin zymography, cell counting kit-8, colony formation, wound healing, migration and invasion assays mmunoprecipitation was performed to in vitro. Immunoprecipitation was performed to test the interaction of c-Jun and ATF2. Chromatin immunoprecipitation was conducted to assess the transcriptional regulation of ATF2/c-Jun on MMP-2/9. Moreover, the tumorigenicity of ANKRD49 was evaluated in nude mice models and the involved signal molecular was also measured by immunohistochemical method.
Results:
We found that the levels of ANKRD49 in cancerous tissues were higher than those in adjacent normal tissues. in vitro assay showed that ANKRD49 promoted the migration and invasion of NCI-H1299 and NCI-H1703 cells via enhancing the levels of MMP-2 and MMP-9. Furthermore, ANKRD49 elevated phosphorylation of JNK and then activated c-Jun and ATF2 which interact in nucleus to promote the binding of ATF2:c-Jun with the promoter MMP-2 or MMP-9. In vivo assay showed that ANKRD49 promoted lung metastasis of injected-NSCLC cells and the high metastatic rate was positively correlated with the high expression of ANKRD49, MMP-2, MMP-9, p-JNK, p-c-Jun and p-ATF2.
Conclusion:
The present study indicated that ANKRD49 accelerated the invasion and metastasis of NSCLC cells via JNK-mediated transcription activation of c-Jun and ATF2 which regulated the expression of MMP-2/MMP-9. The molecular mechanisms of ANKRD49's function is different from those found in A549 cells. The current study is a supplement and improvement to the previous research.
Insights
Ankyrin repeat domain 49 (ANKRD49) promotes non-small cell lung cancer (NSCLC) invasion and metastasis by activating JNK signaling, which upregulates MMP-2/MMP-9 expression through c-Jun and ATF2. This study clarifies ANKRD49
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Ankyrin repeat domain 49 (ANKRD49) is highly expressed in lung adenocarcinoma (LUAD) and lung squamous carcinoma (LUSC).
- The precise role of ANKRD49 in non-small cell lung cancer (NSCLC) pathogenesis remains unclear.
- Previous studies suggested ANKRD49 promotes LUAD cell invasion via the p38-ATF-2-MMP2/MMP9 pathway.
Purpose of the Study:
- To investigate the function and mechanism of ANKRD49 in NSCLC using various cell lines.
- To elucidate the signaling pathways and molecular targets regulated by ANKRD49 in NSCLC.
- To validate the role of ANKRD49 in NSCLC tumorigenicity and metastasis in vivo.
Main Methods:
- Real-time qPCR to assess ANKRD49 expression in NSCLC tissues and adjacent normal tissues.
- In vitro assays (overexpression, RNA interference, gelatin zymography, CCK-8, colony formation, wound healing, migration, invasion) in NCI-H1299 and NCI-H1703 cells.
- Immunoprecipitation, chromatin immunoprecipitation, and nude mouse models to analyze molecular interactions, transcriptional regulation, and tumorigenicity.
Main Results:
- ANKRD49 expression is significantly higher in NSCLC tissues compared to normal tissues.
- ANKRD49 overexpression enhances migration and invasion in NSCLC cells by increasing MMP-2 and MMP-9 levels.
- ANKRD49 activates the JNK pathway, leading to c-Jun and ATF2 phosphorylation and subsequent transcriptional activation of MMP-2/MMP-9 promoters.
Conclusions:
- ANKRD49 promotes NSCLC cell invasion and metastasis through JNK-mediated transcriptional activation of MMP-2/MMP-9 via c-Jun and ATF2.
- The identified molecular mechanism differs from previously reported pathways in A549 cells, highlighting NSCLC heterogeneity.
- This study provides a comprehensive understanding of ANKRD49's role in NSCLC progression and metastasis.
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
PI3K/mTOR/AKT Signaling Pathway
Abnormal Proliferation
Intracellular Signaling Affects Focal Adhesions
Some...

